首页 > 最新文献

Cancer Epidemiology Biomarkers & Prevention最新文献

英文 中文
Tobacco Biomarkers by Latino Heritage and Race, U.S., 2007-2014 National Health and Nutrition Examination Survey. 按拉丁裔血统和种族划分的烟草生物标志物,美国,2007-2014 年全国健康与营养调查。
IF 3.7 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-30 DOI: 10.1158/1055-9965.EPI-24-0744
Chelsea Duong, Erik J Rodriquez, Amanda S Hinerman, Somy Hooshmand, Sophie E Claudel, Neal L Benowitz, Eliseo J Perez-Stable

Background: Tobacco biomarkers reflect smoking intensity and are used to assess cessation status. No study has evaluated variation by Latino heritage.

Methods: Data from the 2007-2014 National Health and Nutrition Examination Survey were used to evaluate geometric mean concentrations of serum cotinine and urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), stratified by smoking status and race and ethnicity, and receiver operating characteristic curves estimated values to distinguish smokers from non-smokers by race and ethnicity and Latino heritage.

Results: The sample (n=18,597) was 50.1% female, 16.6% Latino (58.6% Mexican, 10.4% Central American, 9.1% South American, 7.3% Puerto Rican, 3.5% Dominican, 2.7% Cuban, 8.4% Other Latinos, overall), 12.7% Black, and 70.7% White. Black non-smokers and smokers had the highest cotinine concentrations (0.1 ng/mL and 177.1 ng/mL) and among non-smokers, Black individuals had the highest NNAL concentrations (1.4 pg/mL). Latino smokers had the lowest cotinine (32.7 ng/mL) and NNAL (63.9 pg/mL) concentrations. Among Latino smokers, Puerto Rican individuals had higher concentrations of cotinine (100.0 ng/mL) and NNAL (136.4 pg/mL). Cotinine levels defining smoking (Black: 9.1 ng/mL, Latino: 0.9 ng/mL, White: 3.8 ng/mL) and NNAL (Black: 24.1 pg/mL, Latino: 5.7 pg/mL, White: 15.5 pg/mL) varied. Puerto Rican adults (cotinine: 8.5 ng/mL, NNAL: 17.2 pg/mL) had higher levels than Central American (cotinine: 1.0 ng/mL, NNAL: 5.5 pg/mL) and Mexican (cotinine: 0.9 ng/mL, NNAL: 6.0 pg/mL) adults.

Conclusions: Cotinine and NNAL concentrations that define smoking differed by race and ethnicity and by heritage among Latinos, showing meaningful differences.

Impact: Cessation interventions with biomarker validation need to consider Latino heritage.

背景:烟草生物标志物可反映吸烟强度,并用于评估戒烟状况。目前还没有研究对拉丁裔血统的差异进行评估:方法:利用2007-2014年美国国家健康与营养调查的数据,评估血清可替宁和尿液中4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁醇(NNAL)总浓度的几何平均浓度,按吸烟状况、种族和民族进行分层,并通过接收器操作特征曲线估算出按种族、民族和拉丁裔区分吸烟者与非吸烟者的数值:样本(n=18,597)中女性占 50.1%,拉丁裔占 16.6%(墨西哥裔占 58.6%,中美洲裔占 10.4%,南美洲裔占 9.1%,波多黎各裔占 7.3%,多米尼加裔占 3.5%,古巴裔占 2.7%,其他拉丁裔占 8.4%),黑人占 12.7%,白人占 70.7%。黑人非吸烟者和吸烟者的可替宁浓度最高(0.1 纳克/毫升和 177.1 纳克/毫升),在非吸烟者中,黑人的 NNAL 浓度最高(1.4 皮克/毫升)。拉丁裔吸烟者的可替宁(32.7 纳克/毫升)和 NNAL(63.9 皮克/毫升)浓度最低。在拉丁裔吸烟者中,波多黎各人的可替宁(100.0 纳克/毫升)和 NNAL(136.4 皮克/毫升)浓度较高。定义吸烟的可替宁水平(黑人:9.1 纳克/毫升,拉丁裔:0.9 纳克/毫升,白人:3.8 纳克/毫升)和 NNAL 水平(黑人:24.1 皮克/毫升,拉丁裔:5.7 皮克/毫升,白人:15.5 皮克/毫升)各不相同。波多黎各成年人(可替宁:8.5 纳克/毫升,NNAL:17.2 皮克/毫升)的水平高于中美洲成年人(可替宁:1.0 纳克/毫升,NNAL:5.5 皮克/毫升)和墨西哥成年人(可替宁:0.9 纳克/毫升,NNAL:6.0 皮克/毫升):结论:在拉美裔人群中,可替宁和 NNAL 的浓度因种族、民族和血统而异,显示出有意义的差异:影响:通过生物标志物验证的戒烟干预措施需要考虑拉丁裔血统。
{"title":"Tobacco Biomarkers by Latino Heritage and Race, U.S., 2007-2014 National Health and Nutrition Examination Survey.","authors":"Chelsea Duong, Erik J Rodriquez, Amanda S Hinerman, Somy Hooshmand, Sophie E Claudel, Neal L Benowitz, Eliseo J Perez-Stable","doi":"10.1158/1055-9965.EPI-24-0744","DOIUrl":"https://doi.org/10.1158/1055-9965.EPI-24-0744","url":null,"abstract":"<p><strong>Background: </strong>Tobacco biomarkers reflect smoking intensity and are used to assess cessation status. No study has evaluated variation by Latino heritage.</p><p><strong>Methods: </strong>Data from the 2007-2014 National Health and Nutrition Examination Survey were used to evaluate geometric mean concentrations of serum cotinine and urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), stratified by smoking status and race and ethnicity, and receiver operating characteristic curves estimated values to distinguish smokers from non-smokers by race and ethnicity and Latino heritage.</p><p><strong>Results: </strong>The sample (n=18,597) was 50.1% female, 16.6% Latino (58.6% Mexican, 10.4% Central American, 9.1% South American, 7.3% Puerto Rican, 3.5% Dominican, 2.7% Cuban, 8.4% Other Latinos, overall), 12.7% Black, and 70.7% White. Black non-smokers and smokers had the highest cotinine concentrations (0.1 ng/mL and 177.1 ng/mL) and among non-smokers, Black individuals had the highest NNAL concentrations (1.4 pg/mL). Latino smokers had the lowest cotinine (32.7 ng/mL) and NNAL (63.9 pg/mL) concentrations. Among Latino smokers, Puerto Rican individuals had higher concentrations of cotinine (100.0 ng/mL) and NNAL (136.4 pg/mL). Cotinine levels defining smoking (Black: 9.1 ng/mL, Latino: 0.9 ng/mL, White: 3.8 ng/mL) and NNAL (Black: 24.1 pg/mL, Latino: 5.7 pg/mL, White: 15.5 pg/mL) varied. Puerto Rican adults (cotinine: 8.5 ng/mL, NNAL: 17.2 pg/mL) had higher levels than Central American (cotinine: 1.0 ng/mL, NNAL: 5.5 pg/mL) and Mexican (cotinine: 0.9 ng/mL, NNAL: 6.0 pg/mL) adults.</p><p><strong>Conclusions: </strong>Cotinine and NNAL concentrations that define smoking differed by race and ethnicity and by heritage among Latinos, showing meaningful differences.</p><p><strong>Impact: </strong>Cessation interventions with biomarker validation need to consider Latino heritage.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
History of infertility and risk of endometrial cancer in the Women's Health Initiative. 妇女健康倡议 "中的不孕史与子宫内膜癌风险。
IF 3.7 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-30 DOI: 10.1158/1055-9965.EPI-24-0717
Holly R Harris, Kathylynn Saboda, Cynthia A Thomson, Nazmus Saquib, Aladdin H Shadyab, Peter F Schnatz, Rogelio Robles-Morales, Lihong Qi, Denise J Roe, Leslie V Farland

Background: Several studies have suggested an association between infertility and risk of endometrial cancer. However, most studies have evaluated this relationship in premenopausal people, yet the mean age of endometrial cancer is 60 years old, after the average age of menopause.

Methods: Our study included Women's Health Initiative participants who self-reported whether they had a history of infertility. Cox proportional hazards models were used to examine the association between infertility and incident endometrial cancer. Given that all infertility diagnoses occurred prior to study enrollment, we conducted secondary analyses using logistic regression examining prevalent endometrial cancer cases diagnosed before study baseline.

Results: Approximately 18% of participants reported a history of infertility. No statistically significant association was observed between infertility and risk of incident endometrial cancer overall (incident cases=1622; hazard ratio [HR]=1.12; 95% confidence interval [CI]=0.99-1.26). While point estimates suggested an increase in risk of endometrial cancer among women with BMI ≥25 (HR=1.15; 95% CI=0.99-1.33), none of the associations were statistically significant. There was an association between history of infertility and prevalent endometrial cancer cases (odds ratio [OR]=1.19; 95% CI=1.06-1.34), with the strongest association for infertility diagnosis due to endometriosis (OR=2.42; 95% CI=1.83-3.19).

Conclusions: In a population of postmenopausal participants, we observed a modest, but not statistically significant, association between overall infertility and incident endometrial cancer, with the suggestion of a higher risk among those with a BMI ≥25.

Impact: Our findings highlight, as observed in previous studies, that risk factors for endometrial cancer may vary by body mass index.

背景:多项研究表明,不孕症与子宫内膜癌的发病风险有关。然而,大多数研究都是在绝经前的人群中评估这种关系,而子宫内膜癌的平均发病年龄是 60 岁,即绝经后的平均年龄:我们的研究纳入了妇女健康行动的参与者,他们自述是否有不孕史。我们采用 Cox 比例危险模型来研究不孕症与子宫内膜癌发病之间的关系。鉴于所有不孕症的诊断都发生在研究注册之前,我们使用逻辑回归对研究基线之前诊断出的子宫内膜癌病例进行了二次分析:约 18% 的参与者报告有不孕史。不孕症与子宫内膜癌发病风险之间没有统计学意义(发病病例=1622;危险比 [HR] =1.12;95% 置信区间 [CI] =0.99-1.26)。虽然点估计值表明体重指数≥25的妇女罹患子宫内膜癌的风险会增加(HR=1.15;95% CI=0.99-1.33),但这些关联均无统计学意义。不孕史与子宫内膜癌发病率之间存在关联(几率比[OR]=1.19;95% CI=1.06-1.34),其中与子宫内膜异位症导致的不孕诊断关联最大(OR=2.42;95% CI=1.83-3.19):在绝经后人群中,我们观察到总体不孕症与子宫内膜癌之间存在适度的关联,但在统计学上并不显著,这表明体重指数(BMI)≥25.Impact 的人群患子宫内膜癌的风险更高:我们的研究结果强调,正如之前的研究一样,子宫内膜癌的风险因素可能因体重指数而异。
{"title":"History of infertility and risk of endometrial cancer in the Women's Health Initiative.","authors":"Holly R Harris, Kathylynn Saboda, Cynthia A Thomson, Nazmus Saquib, Aladdin H Shadyab, Peter F Schnatz, Rogelio Robles-Morales, Lihong Qi, Denise J Roe, Leslie V Farland","doi":"10.1158/1055-9965.EPI-24-0717","DOIUrl":"https://doi.org/10.1158/1055-9965.EPI-24-0717","url":null,"abstract":"<p><strong>Background: </strong>Several studies have suggested an association between infertility and risk of endometrial cancer. However, most studies have evaluated this relationship in premenopausal people, yet the mean age of endometrial cancer is 60 years old, after the average age of menopause.</p><p><strong>Methods: </strong>Our study included Women's Health Initiative participants who self-reported whether they had a history of infertility. Cox proportional hazards models were used to examine the association between infertility and incident endometrial cancer. Given that all infertility diagnoses occurred prior to study enrollment, we conducted secondary analyses using logistic regression examining prevalent endometrial cancer cases diagnosed before study baseline.</p><p><strong>Results: </strong>Approximately 18% of participants reported a history of infertility. No statistically significant association was observed between infertility and risk of incident endometrial cancer overall (incident cases=1622; hazard ratio [HR]=1.12; 95% confidence interval [CI]=0.99-1.26). While point estimates suggested an increase in risk of endometrial cancer among women with BMI ≥25 (HR=1.15; 95% CI=0.99-1.33), none of the associations were statistically significant. There was an association between history of infertility and prevalent endometrial cancer cases (odds ratio [OR]=1.19; 95% CI=1.06-1.34), with the strongest association for infertility diagnosis due to endometriosis (OR=2.42; 95% CI=1.83-3.19).</p><p><strong>Conclusions: </strong>In a population of postmenopausal participants, we observed a modest, but not statistically significant, association between overall infertility and incident endometrial cancer, with the suggestion of a higher risk among those with a BMI ≥25.</p><p><strong>Impact: </strong>Our findings highlight, as observed in previous studies, that risk factors for endometrial cancer may vary by body mass index.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142342178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers and Prognostic Stratification of Squamous Cell Carcinoma of the Oral Cavity in Young Adults: how to personalize therapeutic management? 年轻人口腔鳞状细胞癌的生物标志物和预后分层:如何进行个性化治疗?
IF 3.7 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-19 DOI: 10.1158/1055-9965.EPI-24-1091
Antoine Dubray-Vautrin, Guillaume Rougier, Christophe Le Tourneau, Wahib Ghanem, Nathalie Badois, Maria Lesnik, Baptiste Sabran, Laurence Bozec, Joey Martin, Olivier Choussy

Squamous cell carcinomas (SCCs) of the oral cavity in young adults represent a heterogeneous entity. New prognostic biomarkers are described in the literature. The aim was to identify emerging biomarkers and prognostic stratification factors of young population. Clinical, biological, microbiological, histopathological, and molecular markers statistically associated with overall and disease-free survival (OS) and validated in literature. Young adults < 40 years who were non-smokers showed a marginally worse prognosis, while age < 30 years was unfavorable compared to > 30 years. High rate of Neutrophil-to-lymphocyte ratio (NLR) was associated with decreased 5-year disease-specific survival, PDL1 expression correlated with improved OS and recurrence-free survival, presence of Fusobacterium, Mutations in p53, Cyclin D1, and VEGF was associated with reduced OS. Combining these markers in young adult oral cavity SCCs should be used to adapt the intensification of therapy in addition to the TNM classification and minor histo-prognostic factors.

青壮年口腔鳞状细胞癌(SCC)是一种异质性肿瘤。文献中描述了新的预后生物标志物。研究的目的是确定新出现的生物标志物和年轻人群的预后分层因素。临床、生物学、微生物学、组织病理学和分子标记与总生存期和无病生存期(OS)相关,并在文献中得到验证。年龄小于40岁且不吸烟的年轻人预后稍差,而年龄小于30岁的年轻人预后比大于30岁的年轻人差。中性粒细胞与淋巴细胞比值(NLR)高与5年疾病特异性生存率降低有关,PDL1表达与OS和无复发生存率改善有关,Fusobacterium、p53、Cyclin D1和VEGF突变与OS降低有关。除了TNM分类和次要组织预后因素外,还应结合这些标记物来调整年轻成人口腔SCC的强化治疗。
{"title":"Biomarkers and Prognostic Stratification of Squamous Cell Carcinoma of the Oral Cavity in Young Adults: how to personalize therapeutic management?","authors":"Antoine Dubray-Vautrin, Guillaume Rougier, Christophe Le Tourneau, Wahib Ghanem, Nathalie Badois, Maria Lesnik, Baptiste Sabran, Laurence Bozec, Joey Martin, Olivier Choussy","doi":"10.1158/1055-9965.EPI-24-1091","DOIUrl":"https://doi.org/10.1158/1055-9965.EPI-24-1091","url":null,"abstract":"<p><p>Squamous cell carcinomas (SCCs) of the oral cavity in young adults represent a heterogeneous entity. New prognostic biomarkers are described in the literature. The aim was to identify emerging biomarkers and prognostic stratification factors of young population. Clinical, biological, microbiological, histopathological, and molecular markers statistically associated with overall and disease-free survival (OS) and validated in literature. Young adults < 40 years who were non-smokers showed a marginally worse prognosis, while age < 30 years was unfavorable compared to > 30 years. High rate of Neutrophil-to-lymphocyte ratio (NLR) was associated with decreased 5-year disease-specific survival, PDL1 expression correlated with improved OS and recurrence-free survival, presence of Fusobacterium, Mutations in p53, Cyclin D1, and VEGF was associated with reduced OS. Combining these markers in young adult oral cavity SCCs should be used to adapt the intensification of therapy in addition to the TNM classification and minor histo-prognostic factors.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma in Situ of the Breast 居住地隔离在乳腺原位导管癌治疗和结果中的作用
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-18 DOI: 10.1158/1055-9965.epi-24-0488
Oumarou Nabi, Ying Liu, James Struthers, Min Lian
Background: It remains unclear if residential segregation impacts on clinical treatment and outcomes for ductal carcinoma in situ (DCIS), a nonobligate precursor to invasive breast cancer (IBC). Methods: This population-based retrospective cohort study included adult non-Hispanic White (NHW) and Black (NHB) women diagnosed with unilateral DCIS between January 1990 and December 2015, followed through December 2016, and identified from the Surveillance, Epidemiology, and End Results dataset. County-level racialized economic segregation was measured using the Index of Concentration at the Extremes. Multilevel logistic regression and Cox proportional hazards regression accounting for county-level clustering were used to estimate the odds ratios (ORs) of local treatment, and hazard ratios (HRs) of subsequent IBC and mortality. Results: Of 103,898 cases, mean age was 59.5 years, 12.5% were NHB, 87.5% were NHW, 97.5% underwent surgery, 64.5% received radiotherapy following breast-conserving surgery, 7.1% developed IBC, and 18.6% died from all causes. Among women living in the least vs most privileged counties, we observed higher odds of receiving mastectomy (vs breast-conserving surgery) (OR=1.51, 95% CI 1.35-1.69; Ptrend&lt;0.001) and radiation therapy following breast-conserving surgery (OR=1.27, 95% CI 1.07-1.51; Ptrend&lt;0.01); the risk was higher in subsequent ipsilateral IBC (HR=1.16, 95% CI 1.02-1.32; Ptrend=0.04), not in breast cancer-specific mortality (HR=1.04, 95% CI 0.88-1.23; Ptrend=0.56). Conclusions: The results provide evidence for disparities in clinical treatment for DCIS and prognostic outcomes among women in racially and economically segregated counties. Impact: Our findings may inform geographically targeted multilevel interventions to reduce breast cancer burden and improve breast cancer care and equity.
背景:乳腺导管原位癌(DCIS)是侵袭性乳腺癌(IBC)的非潜在前体,目前尚不清楚居住地隔离是否会影响其临床治疗和预后。研究方法这项基于人群的回顾性队列研究纳入了1990年1月至2015年12月期间被诊断为单侧DCIS的非西班牙裔白人(NHW)和黑人(NHB)成年女性,随访至2016年12月,并从 "监测、流行病学和最终结果 "数据集中识别。县级种族化经济隔离采用极端集中指数(Index of Concentration at the Extremmes)进行测量。多层次逻辑回归和考克斯比例危害回归考虑了县级聚类,用于估计当地治疗的几率比(ORs)以及后续 IBC 和死亡率的危害比(HRs)。结果:在 103,898 个病例中,平均年龄为 59.5 岁,12.5% 为非华裔女性,87.5% 为非华裔女性,97.5% 接受了手术,64.5% 在保乳手术后接受了放疗,7.1% 发展为 IBC,18.6% 死于各种原因。在生活条件最差的县与生活条件最好的县的妇女中,我们观察到接受乳房切除术(与保乳手术相比)(OR=1.51,95% CI 1.35-1.69;Ptrend&lt;0.001)和保乳手术后接受放射治疗(OR=1.27,95% CI 1.07-1.51;Ptrend&lt;0.01);随后同侧 IBC 的风险更高(HR=1.16,95% CI 1.02-1.32;Ptrend=0.04),而乳腺癌特异性死亡率(HR=1.04,95% CI 0.88-1.23;Ptrend=0.56)则不高。结论研究结果证明,在种族和经济隔离县的妇女中,DCIS 的临床治疗和预后结果存在差异。影响:我们的研究结果可为有地域针对性的多层次干预措施提供信息,以减轻乳腺癌负担并改善乳腺癌护理和公平性。
{"title":"The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma in Situ of the Breast","authors":"Oumarou Nabi, Ying Liu, James Struthers, Min Lian","doi":"10.1158/1055-9965.epi-24-0488","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0488","url":null,"abstract":"Background: It remains unclear if residential segregation impacts on clinical treatment and outcomes for ductal carcinoma in situ (DCIS), a nonobligate precursor to invasive breast cancer (IBC). Methods: This population-based retrospective cohort study included adult non-Hispanic White (NHW) and Black (NHB) women diagnosed with unilateral DCIS between January 1990 and December 2015, followed through December 2016, and identified from the Surveillance, Epidemiology, and End Results dataset. County-level racialized economic segregation was measured using the Index of Concentration at the Extremes. Multilevel logistic regression and Cox proportional hazards regression accounting for county-level clustering were used to estimate the odds ratios (ORs) of local treatment, and hazard ratios (HRs) of subsequent IBC and mortality. Results: Of 103,898 cases, mean age was 59.5 years, 12.5% were NHB, 87.5% were NHW, 97.5% underwent surgery, 64.5% received radiotherapy following breast-conserving surgery, 7.1% developed IBC, and 18.6% died from all causes. Among women living in the least vs most privileged counties, we observed higher odds of receiving mastectomy (vs breast-conserving surgery) (OR=1.51, 95% CI 1.35-1.69; Ptrend&amp;lt;0.001) and radiation therapy following breast-conserving surgery (OR=1.27, 95% CI 1.07-1.51; Ptrend&amp;lt;0.01); the risk was higher in subsequent ipsilateral IBC (HR=1.16, 95% CI 1.02-1.32; Ptrend=0.04), not in breast cancer-specific mortality (HR=1.04, 95% CI 0.88-1.23; Ptrend=0.56). Conclusions: The results provide evidence for disparities in clinical treatment for DCIS and prognostic outcomes among women in racially and economically segregated counties. Impact: Our findings may inform geographically targeted multilevel interventions to reduce breast cancer burden and improve breast cancer care and equity.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial, Ethnic, and Socioeconomic Disparities in Meeting Physical Activity Guidelines among Female Breast Cancer Survivors in the United States 美国乳腺癌女性幸存者在达到体育锻炼指南要求方面的种族、民族和社会经济差异
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-13 DOI: 10.1158/1055-9965.epi-24-0650
Kaitlyn M. Wojcik, Oliver W.A. Wilson, Meredith S. Shiels, Vanessa L. Sheppard, Jinani Jayasekera
Background: Cancer survivors show low physical activity participation rates in the U.S. However, there are limited national-level data on disparities in the prevalence of meeting physical activity guidelines among women with and without breast cancer. We aimed to evaluate national-level trends in meeting physical activity guidelines across demographic and socioeconomic characteristics of breast cancer survivors and women without cancer. Methods: Data for women aged ≥35-years with and without breast cancer were obtained from the 2004-2018 National Health Interview Survey (NHIS). We used NHIS survey weights to generate national-level prevalence estimates and calculate absolute and relative indices of disparity for breast cancer survivors and women without cancer meeting aerobic (150-mins/week) and muscle strengthening guidelines (2-sessions/week) stratified by demographic (e.g., race/ethnicity) and socioeconomic (e.g., homeownership) characteristics. Results: We included 5,845 breast cancer survivors and 160,162 women without cancer. The weighted percentage of breast cancer survivors meeting aerobic guidelines was 37.7% compared to 40.9% of women without cancer. Fewer women met muscle strengthening guidelines. There were lower proportions of women who were younger (&lt;50-years), were non-Hispanic Black, were Hispanic, worked 35+ hours/week, or rented their home among breast cancer survivors meeting aerobic guidelines compared to women without cancer meeting aerobic guidelines. Conclusions: Breast cancer survivors were less likely to meet physical activity guidelines compared to women without cancer. Demographic and socioeconomic disparities may exist among breast cancer survivors and women without cancer meeting physical activity guidelines. Impact: Targeted interventions may be necessary to address low physical activity participation among breast cancer survivors.
背景:在美国,癌症幸存者的体育锻炼参与率很低。然而,关于乳腺癌女性患者和非乳腺癌女性患者在达到体育锻炼指南要求方面的差异的国家级数据却很有限。我们的目的是评估全国范围内乳腺癌幸存者和未患乳腺癌妇女在满足体育锻炼指南要求方面的趋势,包括人口和社会经济特征。方法:我们从 2004-2018 年全国健康访谈调查(NHIS)中获得了年龄≥35 岁的乳腺癌女性患者和非乳腺癌女性患者的数据。我们使用 NHIS 调查加权得出全国水平的患病率估计值,并计算出符合有氧运动(150 分钟/周)和肌肉强化指南(2 次/周)的乳腺癌幸存者和未患乳腺癌女性的绝对和相对差异指数,这些差异指数按人口统计学特征(如种族/民族)和社会经济特征(如房屋所有权)进行分层。结果:我们纳入了 5,845 名乳腺癌幸存者和 160,162 名未患癌症的女性。符合有氧运动指南的乳腺癌幸存者的加权百分比为 37.7%,而未患癌症的妇女为 40.9%。符合肌肉锻炼指南的女性人数较少。与符合有氧运动指南的未患癌症女性相比,符合有氧运动指南的乳腺癌幸存者中年龄较小(50 岁)、非西班牙裔黑人、西班牙裔、每周工作 35 小时以上或租房居住的女性比例较低。结论:与未患癌症的妇女相比,乳腺癌幸存者达到体育锻炼指南要求的可能性较低。在符合体育锻炼指南的乳腺癌幸存者和未患癌症的女性中,可能存在人口和社会经济方面的差异。影响:可能有必要采取有针对性的干预措施来解决乳腺癌幸存者参加体育锻炼少的问题。
{"title":"Racial, Ethnic, and Socioeconomic Disparities in Meeting Physical Activity Guidelines among Female Breast Cancer Survivors in the United States","authors":"Kaitlyn M. Wojcik, Oliver W.A. Wilson, Meredith S. Shiels, Vanessa L. Sheppard, Jinani Jayasekera","doi":"10.1158/1055-9965.epi-24-0650","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0650","url":null,"abstract":"Background: Cancer survivors show low physical activity participation rates in the U.S. However, there are limited national-level data on disparities in the prevalence of meeting physical activity guidelines among women with and without breast cancer. We aimed to evaluate national-level trends in meeting physical activity guidelines across demographic and socioeconomic characteristics of breast cancer survivors and women without cancer. Methods: Data for women aged ≥35-years with and without breast cancer were obtained from the 2004-2018 National Health Interview Survey (NHIS). We used NHIS survey weights to generate national-level prevalence estimates and calculate absolute and relative indices of disparity for breast cancer survivors and women without cancer meeting aerobic (150-mins/week) and muscle strengthening guidelines (2-sessions/week) stratified by demographic (e.g., race/ethnicity) and socioeconomic (e.g., homeownership) characteristics. Results: We included 5,845 breast cancer survivors and 160,162 women without cancer. The weighted percentage of breast cancer survivors meeting aerobic guidelines was 37.7% compared to 40.9% of women without cancer. Fewer women met muscle strengthening guidelines. There were lower proportions of women who were younger (&amp;lt;50-years), were non-Hispanic Black, were Hispanic, worked 35+ hours/week, or rented their home among breast cancer survivors meeting aerobic guidelines compared to women without cancer meeting aerobic guidelines. Conclusions: Breast cancer survivors were less likely to meet physical activity guidelines compared to women without cancer. Demographic and socioeconomic disparities may exist among breast cancer survivors and women without cancer meeting physical activity guidelines. Impact: Targeted interventions may be necessary to address low physical activity participation among breast cancer survivors.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression 前列腺肿瘤免疫景观与剧烈运动和前列腺癌进展的关系
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-13 DOI: 10.1158/1055-9965.epi-24-0263
Lanshan Huang, Sarah J. Winter, Linnea T. Olsson, Alina M. Hamilton, Sophia R. Halliday, Erin L. Kirk, Laura Farnan, Adrian Gerstel, Stephanie G. Craig, Stephen P. Finn, Melissa LaBonte Wilson, Suneil Jain, Melissa A. Troester, Eboneé N. Butler, Jeannette T. Bensen, Sara E. Wobker, Emma H. Allott
Background: Vigorous physical activity has been associated with lower risk of fatal prostate cancer. However, mechanisms contributing to this relationship are not understood. Methods: We studied 117 men with prostate cancer in the University of North Carolina Cancer Survivorship Cohort (UNC CSC) who underwent radical prostatectomy, and 101 radiation-treated prostate cancer patients in FASTMAN. Structured questionnaires administered in UNC CSC assessed physical activity. In both studies, digital image analysis of H&E-stained tissues was applied to quantify Tumor Infiltrating Lymphocytes (TILs) in segmented regions. Nanostring gene expression profiling in UNC CSC and microarray in FASTMAN were performed on tumor tissue and a 50-gene signature utilized to predict immune cell types. Results: Vigorous recreational activity, reported by 34 (29.1%) UNC men, was inversely associated with TILs abundance. Tumors of men reporting any vigorous activity versus none showed lower gene expression-predicted abundance of Th, exhausted CD4 T cells and macrophages. T cell subsets, including Treg, Th, Tfh, exhausted CD4 T cells, and macrophages were associated with increased risk of biochemical recurrence, only among men with ERG-positive tumors. Conclusions: Vigorous activity was associated with lower prostate tumor inflammation and immune microenvironment differences. Macrophages and T cell subsets, including those with immunosuppressive roles and those with lower abundance in men reporting vigorous exercise, were associated with worse outcomes in ERG-positive prostate cancer. Impact: Our novel findings contribute to our understanding of the role of the tumor immune microenvironment in prostate cancer progression, and may provide insight into how vigorous exercise could affect prostate tumor biology.
背景:剧烈运动与致命前列腺癌风险降低有关。然而,造成这种关系的机制尚不清楚。研究方法我们研究了北卡罗来纳大学癌症幸存者队列(UNC CSC)中接受根治性前列腺切除术的 117 名前列腺癌男性患者,以及 FASTMAN 中接受放射治疗的 101 名前列腺癌患者。在 UNC CSC 中进行的结构化问卷调查对体力活动进行了评估。在这两项研究中,H&E染色组织的数字图像分析被用来量化分割区域中的肿瘤浸润淋巴细胞(TIL)。在 UNC CSC 中对肿瘤组织进行了纳米抗原基因表达谱分析,在 FASTMAN 中对肿瘤组织进行了微阵列分析,并利用 50 个基因特征来预测免疫细胞类型。研究结果34名(29.1%)UNC男性报告了剧烈的娱乐活动,这与TILs的数量成反比。有剧烈活动与无剧烈活动的男性肿瘤中,Th、衰竭CD4 T细胞和巨噬细胞的基因表达预测丰度较低。T细胞亚群(包括Treg、Th、Tfh、CD4 T细胞衰竭和巨噬细胞)与生化复发风险的增加有关,仅在ERG阳性肿瘤男性中存在。结论是剧烈活动与较低的前列腺肿瘤炎症和免疫微环境差异有关。巨噬细胞和T细胞亚群,包括那些具有免疫抑制作用的亚群和那些在报告剧烈运动的男性中丰度较低的亚群,与ERG阳性前列腺癌较差的预后有关。影响:我们的新发现有助于我们了解肿瘤免疫微环境在前列腺癌进展过程中的作用,并可让我们深入了解剧烈运动如何影响前列腺肿瘤生物学。
{"title":"Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression","authors":"Lanshan Huang, Sarah J. Winter, Linnea T. Olsson, Alina M. Hamilton, Sophia R. Halliday, Erin L. Kirk, Laura Farnan, Adrian Gerstel, Stephanie G. Craig, Stephen P. Finn, Melissa LaBonte Wilson, Suneil Jain, Melissa A. Troester, Eboneé N. Butler, Jeannette T. Bensen, Sara E. Wobker, Emma H. Allott","doi":"10.1158/1055-9965.epi-24-0263","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0263","url":null,"abstract":"Background: Vigorous physical activity has been associated with lower risk of fatal prostate cancer. However, mechanisms contributing to this relationship are not understood. Methods: We studied 117 men with prostate cancer in the University of North Carolina Cancer Survivorship Cohort (UNC CSC) who underwent radical prostatectomy, and 101 radiation-treated prostate cancer patients in FASTMAN. Structured questionnaires administered in UNC CSC assessed physical activity. In both studies, digital image analysis of H&amp;E-stained tissues was applied to quantify Tumor Infiltrating Lymphocytes (TILs) in segmented regions. Nanostring gene expression profiling in UNC CSC and microarray in FASTMAN were performed on tumor tissue and a 50-gene signature utilized to predict immune cell types. Results: Vigorous recreational activity, reported by 34 (29.1%) UNC men, was inversely associated with TILs abundance. Tumors of men reporting any vigorous activity versus none showed lower gene expression-predicted abundance of Th, exhausted CD4 T cells and macrophages. T cell subsets, including Treg, Th, Tfh, exhausted CD4 T cells, and macrophages were associated with increased risk of biochemical recurrence, only among men with ERG-positive tumors. Conclusions: Vigorous activity was associated with lower prostate tumor inflammation and immune microenvironment differences. Macrophages and T cell subsets, including those with immunosuppressive roles and those with lower abundance in men reporting vigorous exercise, were associated with worse outcomes in ERG-positive prostate cancer. Impact: Our novel findings contribute to our understanding of the role of the tumor immune microenvironment in prostate cancer progression, and may provide insight into how vigorous exercise could affect prostate tumor biology.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung Cancer Screening Uptake Under the Revised United States Preventive Service Task Force Guideline: Assessing Disparities 美国预防服务工作组指南修订版中的肺癌筛查接受率:评估差异
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-13 DOI: 10.1158/1055-9965.epi-24-0725
Abdi T. Gudina, Charles S. Kamen, Kelly A. Hirko, David H. Adler, Deborah J. Ossip, Edith M. Williams, Vinay K. Cheruvu, Ana-Paula Cupertino
Background: Scanning with low-dose computed tomography reduces lung cancer mortality by 20% among high-risk individuals. Despite its efficacy, the uptake of lung cancer screening (LCS) remains low. Our study aimed to estimate state-level and nationwide LCS rates among eligible individuals and to assess disparities in LCS uptake. Methods: Data for this study were obtained from the 2022 BRFSS. Multivariable logistic regression models were used to model the associations between predictors and outcome variables and to examine LCS variability across states. Results: Of the 28,071 participants eligible for LCS, 17.24% underwent LCS. Participants aged 65 -79 years were (OR: 1.75, 95%CI: 1.54 -1.99) more likely to undergo LCS than their younger counterparts. Those who were female (OR: 0.83, 95%CI: 0.73 - 0.94), divorced, separated, or widowed (OR: 0.85, 95%CI: 0.74-0.98), without health insurance (OR: 0.34, 95%CI: 0.22-0.53), without a primary care provider (OR: 0.29, 95%CI: 0.19-0.44), without COPD or those who did not disclose their COPD status ((OR: 0.35, 95%CI: 0.31-0.40) and (OR: 0.37, 95%CI: 0.19-0.73) respectively)) were less likely to undergo LCS than their respective counterparts. LCS uptake also varied significantly across U.S. states. Conclusions: We observed low uptake of LCS overall, and significant variability in LCS uptake by sociodemographic and health-related factors as well as by state of residence. Impact: The findings from this study have important implications for community health workers and healthcare clinicians and indicate the need to design effective interventions to increase LCS uptake targeting specific subgroups of populations and particular U.S. states.
背景:使用低剂量计算机断层扫描可将高危人群的肺癌死亡率降低 20%。尽管肺癌筛查(LCS)效果显著,但其接受率仍然很低。我们的研究旨在估算各州和全国范围内符合条件者的肺癌筛查率,并评估肺癌筛查接受率的差异。方法:本研究的数据来自 2022 年的 BRFSS。使用多变量逻辑回归模型来模拟预测因素和结果变量之间的关联,并检查各州的 LCS 变异性。结果:在 28071 名符合 LCS 条件的参与者中,17.24% 接受了 LCS。65 -79 岁的参与者(OR:1.75,95%CI:1.54 -1.99)比年轻人更有可能接受 LCS。女性(OR:0.83,95%CI:0.73 - 0.94)、离婚、分居或丧偶(OR:0.85,95%CI:0.74-0.98)、无医疗保险(OR:0.34,95%CI:0.22-0.53)、无初级保健提供者(OR:0.29,95%CI:0.19-0.44)、无慢性阻塞性肺病(COPD)或未披露其慢性阻塞性肺病状况(OR:0.35,95%CI:0.31-0.40)和(OR:0.37,95%CI:0.19-0.73))的患者接受 LCS 的可能性低于他们各自的同行。美国各州的 LCS 使用率也有很大差异。结论:我们观察到,LCS 的总体接受率较低,而根据社会人口学和健康相关因素以及居住州的不同,LCS 的接受率也存在显著差异。影响:这项研究的结果对社区卫生工作者和医疗临床医生具有重要意义,并表明有必要针对特定人群和美国特定州设计有效的干预措施,以提高LCS的使用率。
{"title":"Lung Cancer Screening Uptake Under the Revised United States Preventive Service Task Force Guideline: Assessing Disparities","authors":"Abdi T. Gudina, Charles S. Kamen, Kelly A. Hirko, David H. Adler, Deborah J. Ossip, Edith M. Williams, Vinay K. Cheruvu, Ana-Paula Cupertino","doi":"10.1158/1055-9965.epi-24-0725","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0725","url":null,"abstract":"Background: Scanning with low-dose computed tomography reduces lung cancer mortality by 20% among high-risk individuals. Despite its efficacy, the uptake of lung cancer screening (LCS) remains low. Our study aimed to estimate state-level and nationwide LCS rates among eligible individuals and to assess disparities in LCS uptake. Methods: Data for this study were obtained from the 2022 BRFSS. Multivariable logistic regression models were used to model the associations between predictors and outcome variables and to examine LCS variability across states. Results: Of the 28,071 participants eligible for LCS, 17.24% underwent LCS. Participants aged 65 -79 years were (OR: 1.75, 95%CI: 1.54 -1.99) more likely to undergo LCS than their younger counterparts. Those who were female (OR: 0.83, 95%CI: 0.73 - 0.94), divorced, separated, or widowed (OR: 0.85, 95%CI: 0.74-0.98), without health insurance (OR: 0.34, 95%CI: 0.22-0.53), without a primary care provider (OR: 0.29, 95%CI: 0.19-0.44), without COPD or those who did not disclose their COPD status ((OR: 0.35, 95%CI: 0.31-0.40) and (OR: 0.37, 95%CI: 0.19-0.73) respectively)) were less likely to undergo LCS than their respective counterparts. LCS uptake also varied significantly across U.S. states. Conclusions: We observed low uptake of LCS overall, and significant variability in LCS uptake by sociodemographic and health-related factors as well as by state of residence. Impact: The findings from this study have important implications for community health workers and healthcare clinicians and indicate the need to design effective interventions to increase LCS uptake targeting specific subgroups of populations and particular U.S. states.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study 同时诊断为 HIV 和癌症的患者死亡率过高:回顾性队列研究
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-13 DOI: 10.1158/1055-9965.epi-24-0478
Kamaria L. Lee, Varada Sarovar, Jennifer O. Lam, Wendy A. Leyden, Stacey E. Alexeeff, Alexandra N. Lea, Rulin C. Hechter, Haihong Hu, Julia L. Marcus, Qing Yuan, Jennifer R. Kramer, Lilie L. Lin, Elizabeth Y. Chiao, William J. Towner, Michael A. Horberg, Michael J. Silverberg
Background: With extended lifespans for people with human immunodeficiency virus (PWH), there is a corresponding increased burden of chronic illnesses, including cancer. Our objective was to estimate the excess mortality for PWH with cancer compared with people without HIV (PWoH), accounting for the higher background mortality in the general PWH population. Methods: We identified 39,000 PWH and 387,767 demographically-matched PWoH in three integrated healthcare systems from 2000-2016. We estimated excess mortality for PWH with cancer, computed as the cancer mortality rate difference-in-difference comparing PWH and PWoH. We evaluated five cancer groups: any cancer; virus-, human papillomavirus-, and Epstein-Barr virus (EBV)-related cancers; virus-unrelated cancers, and common individual cancers. We fitted a multivariable additive Poisson model to estimate excess mortality for PWH with cancer. Results: PWH with any cancer had excess mortality compared with PWoH (41.3/1000 person-years [py], 95% Confidence Interval [CI] 34.0, 48.7). The highest excess mortality was observed for EBV-related cancers (63.2/1000 py, 95% CI 47.8, 78.7), lung cancer (147.7/1000 py, 95% CI 41.1, 254.3) and non-Hodgkin lymphoma (70.5/1000 py, 95% CI 51.4, 89.6). Excess mortality for PWH was attenuated 2009-2016, and PWH with cancer had no excess mortality 5 years after diagnosis. Conclusions: PWH in care may have excess mortality from certain cancer types, although disparities may have attenuated over time and do not persist beyond 5 years after diagnosis. Impact: Findings may guide improved clinical practice, and suggest further research is needed to investigate whether cancer treatment or other factors contribute to mortality disparities for PWH with cancer.
背景:随着人类免疫缺陷病毒感染者(PWH)寿命的延长,包括癌症在内的慢性病负担也相应增加。我们的目标是估算与未感染艾滋病病毒的人群(PWoH)相比,感染癌症的 PWH 的超额死亡率,同时考虑到一般 PWH 群体中较高的背景死亡率。方法:2000-2016 年间,我们在三个综合医疗系统中识别了 39,000 名艾滋病感染者和 387,767 名人口匹配的艾滋病患者。我们估算了罹患癌症的威利人的超额死亡率,计算方法是威利人与威利人之间的癌症死亡率差异。我们评估了五类癌症:任何癌症;与病毒、人乳头瘤病毒和 Epstein-Barr 病毒 (EBV) 相关的癌症;与病毒无关的癌症以及常见的个体癌症。我们建立了一个多变量加性泊松模型来估算罹患癌症的威尔士人的超额死亡率。结果显示罹患任何癌症的公共卫生人员的死亡率均高于公共卫生人员(41.3/1000 人-年[py],95% 置信区间[CI]34.0, 48.7)。EBV相关癌症(63.2/1000人年,95% CI 47.8,78.7)、肺癌(147.7/1000人年,95% CI 41.1,254.3)和非霍奇金淋巴瘤(70.5/1000人年,95% CI 51.4,89.6)的超额死亡率最高。2009-2016年,威尔士人的超额死亡率有所下降,患有癌症的威尔士人在确诊5年后没有超额死亡率。结论:接受护理的威利人可能会因某些癌症类型而导致超额死亡率,但随着时间的推移,差异可能会减小,并且在确诊后 5 年内不会持续存在。影响:研究结果可为改进临床实践提供指导,并表明需要进一步研究癌症治疗或其他因素是否会导致患有癌症的残疾人死亡率差异。
{"title":"Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study","authors":"Kamaria L. Lee, Varada Sarovar, Jennifer O. Lam, Wendy A. Leyden, Stacey E. Alexeeff, Alexandra N. Lea, Rulin C. Hechter, Haihong Hu, Julia L. Marcus, Qing Yuan, Jennifer R. Kramer, Lilie L. Lin, Elizabeth Y. Chiao, William J. Towner, Michael A. Horberg, Michael J. Silverberg","doi":"10.1158/1055-9965.epi-24-0478","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0478","url":null,"abstract":"Background: With extended lifespans for people with human immunodeficiency virus (PWH), there is a corresponding increased burden of chronic illnesses, including cancer. Our objective was to estimate the excess mortality for PWH with cancer compared with people without HIV (PWoH), accounting for the higher background mortality in the general PWH population. Methods: We identified 39,000 PWH and 387,767 demographically-matched PWoH in three integrated healthcare systems from 2000-2016. We estimated excess mortality for PWH with cancer, computed as the cancer mortality rate difference-in-difference comparing PWH and PWoH. We evaluated five cancer groups: any cancer; virus-, human papillomavirus-, and Epstein-Barr virus (EBV)-related cancers; virus-unrelated cancers, and common individual cancers. We fitted a multivariable additive Poisson model to estimate excess mortality for PWH with cancer. Results: PWH with any cancer had excess mortality compared with PWoH (41.3/1000 person-years [py], 95% Confidence Interval [CI] 34.0, 48.7). The highest excess mortality was observed for EBV-related cancers (63.2/1000 py, 95% CI 47.8, 78.7), lung cancer (147.7/1000 py, 95% CI 41.1, 254.3) and non-Hodgkin lymphoma (70.5/1000 py, 95% CI 51.4, 89.6). Excess mortality for PWH was attenuated 2009-2016, and PWH with cancer had no excess mortality 5 years after diagnosis. Conclusions: PWH in care may have excess mortality from certain cancer types, although disparities may have attenuated over time and do not persist beyond 5 years after diagnosis. Impact: Findings may guide improved clinical practice, and suggest further research is needed to investigate whether cancer treatment or other factors contribute to mortality disparities for PWH with cancer.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142266065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men 非裔美国人和欧裔美国人男性的邻里劣势与前列腺肿瘤侵袭性
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-12 DOI: 10.1158/1055-9965.epi-24-0450
Joseph Boyle, Jessica Yau, Jimmie L. Slade, Derrick A. Butts, Jessica Wimbush, Jong Y. Park, Arif Hussain, Eberechukwu Onukwugha, Cheryl L. Knott, David C. Wheeler, Kathryn Hughes Barry
Background: Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race. Methods: We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021). Results: We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men. Conclusions: We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race. Impact: Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.
背景:研究发现,邻里劣势(ND)与侵袭性前列腺癌之间存在关联,而邻里劣势更有可能影响非裔美国人(AA)。因此,ND 可能会导致前列腺癌的差异。然而,ND 的哪些因素会导致侵袭性疾病,以及不同种族之间的关联是否存在差异,目前还不得而知。研究方法我们评估了在马里兰大学格林鲍姆综合癌症中心接受治疗的前列腺癌男性患者(2004-2021 年)中,侵袭性前列腺癌与四个 ND 指标--地区贫困指数 (ADI)、贝叶斯验证邻里贫困指数 (NDI)、种族隔离 (RI) 指数和历史红线之间的关联,以及这些因素是否与种族相互影响。研究结果我们纳入了 1,458 名男性(698 名欧洲裔美国人和 760 名 AA)。AA 族男性更有可能出现 ND。在调整后的模型中,ADI、RI 和 Redlining 与侵袭性前列腺癌和非侵袭性前列腺癌有显著相关性 [ADI,增加一个 SD 的 OR = 1.14,95% 置信区间 (CI),1.00-1.30;RI,OR = 1.27,CI,1.07-1.51;redlining,OR = 1.77;CI,1.23-2.56],在 AA 族男性中也是如此。在 AA 族男性中,NDI 与侵袭性前列腺癌相关(OR = 1.32,95% 可信区间:1.13-1.57);贫困百分比的重要性权重最大。ADI(P异质性=0.002)和NDI(超出概率异质性=98.1%)与种族有显著的交互作用,因此AA男性的相关性明显更强。结论:我们发现种族隔离和历史红线与侵袭性前列腺癌之间存在新的显著正相关,而且 ND 指数与种族之间存在显著的交互作用。影响:研究结果揭示了与侵袭性前列腺癌相关的特定 ND 成分,并表明 AA 族男性的 ND 效应更强,这对减少差异的干预措施具有重要意义。
{"title":"Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men","authors":"Joseph Boyle, Jessica Yau, Jimmie L. Slade, Derrick A. Butts, Jessica Wimbush, Jong Y. Park, Arif Hussain, Eberechukwu Onukwugha, Cheryl L. Knott, David C. Wheeler, Kathryn Hughes Barry","doi":"10.1158/1055-9965.epi-24-0450","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0450","url":null,"abstract":"Background: Studies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race. Methods: We evaluated associations between aggressive prostate cancer and four ND metrics—Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004–2021). Results: We included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00–1.30; RI, OR = 1.27, CI, 1.07–1.51; redlining, OR = 1.77; CI, 1.23–2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13–1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men. Conclusions: We identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race. Impact: Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142200142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk 开发整合单基因、多基因和流行病学风险的乳腺癌风险预测模型
IF 3.8 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-11 DOI: 10.1158/1055-9965.epi-24-0594
Sarah S. Kalia, Nicholas J. Boddicker, Siddhartha Yadav, Hongyan Huang, Jie Na, Chunling Hu, Christine B. Ambrosone, Song Yao, Christopher A. Haiman, Fei Chen, Esther M. John, Allison W. Kurian, Boya Guo, Sara Lindström, Paul Auer, James V. Lacey, Susan L. Neuhausen, Maria Elena. Martinez, Dale P. Sandler, Katie M. O'Brien, Jack A. Taylor, Lauren R. Teras, James M. Hodge, Adriana Lori, Clara Bodelon, Amy Trentham-Dietz, Elizabeth S. Burnside, Celine M. Vachon, Stacey J. Winham, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Jeffrey N. Weitzel, Fergus J. Couch, Peter Kraft
Background: Breast cancer has been associated with monogenic, polygenic, and epidemiologic (clinical, reproductive and lifestyle) risk factors, but studies evaluating the combined effects of these factors have been limited. Methods: We extended previous work in breast cancer risk modeling, incorporating pathogenic variants (PV) in six breast cancer predisposition genes and a 105-SNP polygenic risk score (PRS), to include an epidemiologic risk score (ERS) in a sample of non-Hispanic White women drawn from prospective cohorts and population-based case-control studies, with 23,518 cases and 22,832 controls, from the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Results: The model predicts 4.4-fold higher risk of breast cancer for postmenopausal women with no predisposition PV and median PRS, but with the highest versus lowest ERS. Overall, women with CHEK2 PVs had &gt;20% lifetime risk of breast cancer. However, 15.6% of women with CHEK2 PVs and a family history of breast cancer, and 45.1% of women with CHEK2 PVs but without a family history of breast cancer, had low (&lt;20%) predicted lifetime risk and thus were below the threshold for MRI screening. CHEK2 PV carriers at the 10th percentile of the joint distribution of ERS and PRS, without a family history of breast cancer, had a predicted lifetime risk similar to the general population. Conclusions: These results illustrate that an ERS, alone and combined with the PRS, can contribute to clinically relevant risk stratification. Impact: Integrating monogenic, polygenic, and epidemiologic risk factors in breast cancer risk prediction models may inform personalized screening and prevention efforts.
背景:乳腺癌与单基因、多基因和流行病学(临床、生殖和生活方式)风险因素有关,但评估这些因素综合影响的研究还很有限。研究方法我们扩展了以前的乳腺癌风险建模工作,将六个乳腺癌易感基因中的致病变异体(PV)和 105-SNP 多基因风险评分(PRS)纳入其中,并将流行病学风险评分(ERS)纳入癌症风险评估易感性(CARRIERS)联盟从前瞻性队列和基于人群的病例对照研究中抽取的非西班牙裔白人女性样本中,其中有 23,518 例病例和 22,832 例对照。研究结果该模型预测绝经后妇女罹患乳腺癌的风险比无易感性PV和中位PRS的妇女高4.4倍,但ERS最高与最低。总体而言,具有 CHEK2 PV 的妇女一生中患乳腺癌的风险为 &gt;20% 。然而,在有乳腺癌家族史的CHEK2 PV女性中,有15.6%的人有乳腺癌家族史;在有乳腺癌家族史的CHEK2 PV女性中,有45.1%的人没有乳腺癌家族史,她们的预测终生乳腺癌风险较低(&lt;20%),因此低于磁共振成像筛查的阈值。处于ERS和PRS联合分布第10百分位的CHEK2 PV携带者,如果没有乳腺癌家族史,其预测终生风险与普通人群相似。结论:这些结果表明,ERS(单独或与 PRS 结合)有助于临床相关的风险分层。影响:在乳腺癌风险预测模型中整合单基因、多基因和流行病学风险因素可为个性化筛查和预防工作提供依据。
{"title":"Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk","authors":"Sarah S. Kalia, Nicholas J. Boddicker, Siddhartha Yadav, Hongyan Huang, Jie Na, Chunling Hu, Christine B. Ambrosone, Song Yao, Christopher A. Haiman, Fei Chen, Esther M. John, Allison W. Kurian, Boya Guo, Sara Lindström, Paul Auer, James V. Lacey, Susan L. Neuhausen, Maria Elena. Martinez, Dale P. Sandler, Katie M. O'Brien, Jack A. Taylor, Lauren R. Teras, James M. Hodge, Adriana Lori, Clara Bodelon, Amy Trentham-Dietz, Elizabeth S. Burnside, Celine M. Vachon, Stacey J. Winham, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Jeffrey N. Weitzel, Fergus J. Couch, Peter Kraft","doi":"10.1158/1055-9965.epi-24-0594","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-24-0594","url":null,"abstract":"Background: Breast cancer has been associated with monogenic, polygenic, and epidemiologic (clinical, reproductive and lifestyle) risk factors, but studies evaluating the combined effects of these factors have been limited. Methods: We extended previous work in breast cancer risk modeling, incorporating pathogenic variants (PV) in six breast cancer predisposition genes and a 105-SNP polygenic risk score (PRS), to include an epidemiologic risk score (ERS) in a sample of non-Hispanic White women drawn from prospective cohorts and population-based case-control studies, with 23,518 cases and 22,832 controls, from the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Results: The model predicts 4.4-fold higher risk of breast cancer for postmenopausal women with no predisposition PV and median PRS, but with the highest versus lowest ERS. Overall, women with CHEK2 PVs had &amp;gt;20% lifetime risk of breast cancer. However, 15.6% of women with CHEK2 PVs and a family history of breast cancer, and 45.1% of women with CHEK2 PVs but without a family history of breast cancer, had low (&amp;lt;20%) predicted lifetime risk and thus were below the threshold for MRI screening. CHEK2 PV carriers at the 10th percentile of the joint distribution of ERS and PRS, without a family history of breast cancer, had a predicted lifetime risk similar to the general population. Conclusions: These results illustrate that an ERS, alone and combined with the PRS, can contribute to clinically relevant risk stratification. Impact: Integrating monogenic, polygenic, and epidemiologic risk factors in breast cancer risk prediction models may inform personalized screening and prevention efforts.","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142225754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Epidemiology Biomarkers & Prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1